Abstract:Tumor-associated macrophages (TAM) subtypes have been shown to impact cancer prognosis and resistance to immunotherapy. However, there is still a lack of systematic investigation into their molecular characteristics and clinical relevance in different cancer types. Single-cell RNA sequencing data from three different tumor types were used to cluster and type macrophages. Functional analysis and communication of TAM subpopulations were performed by Gene Ontology-Biological Process and CellChat respectively. Differential expression of characteristic genes in subpopulations was calculated using zscore as well as edgeR and Wilcoxon rank sum tests, and subsequently gene enrichment analysis of characteristic genes and anti-PD-1 resistance was performed by the REACTOME database. We revealed the heterogeneity of TAM, and identified eleven subtypes and their impact on prognosis. These subtypes expressed different molecular functions respectively, such as being involved in T cell activation, apoptosis and differentiation, or regulating viral bioprocesses or responses to viruses. The SPP1 pathway was identified as a critical mediator of communication between TAM subpopulations, as well as between TAM and epithelial cells. Macrophages with high expression of SPP1 resulted in poorer survival. By in vitro study, we showed SPP1 mediated the interactions between TAM clusters and between TAM and tumor cells. SPP1 promoted the tumor-promoting ability of TAM, and increased PDL1 expression and stemness of tumor cells. Inhibition of SPP1 attenuated N-cadherin and β-catenin expression and the activation of AKT and STAT3 pathway in tumor cells. Additionally, we found that several subpopulations could decrease the sensitivity of anti-PD-1 therapy in melanoma. SPP1 signal was a critical pathway of communication between macrophage subtypes. Some specific macrophage subtypes were associated with immunotherapy resistance and prognosis in some cancer types. Macrophages are natural immune cell-specialized, phagocytic cells, and many studies have been conducted to analyze the functional role of macrophages, but integrating macrophages from multiple cancers to analyze the molecular functions and interactions of macrophages is poorly known.We clustered and typed macrophages using single-cell RNA sequencing data from three different tumor types. Gene Ontology-Biological Processes and Cell Chat were used for functional analysis and communication of TAM subpopulations, respectively. We found heterogeneity of TAM and identified 11 subtypes and their impact on prognosis.The SPP1 pathway is recognized as a key mediator of communication between TAM subpopulations as well as between TAM and epithelial cells, and macrophages with high expression of SPP1 have a lower survival rate. Through in vitro studies, we also found that SPP1 mediated interactions between TAM clusters and between TAM and tumor cells. SPP1 promoted the tumor-promoting ability of TAM and increased PDL1 expression and stemness of tumor cells. In addition, we performed gene enrichment analysis using the REACTOME database and identified subpopulations that decrease the sensitivity of melanoma patients to anti-PD-1 therapy. Some specific macrophage subtypes are associated with immunotherapy resistance and prognosis in certain cancer types.

M1 and M2 macrophage phenotypic diversity in the tumor microenvironment in breast cancer patients: association with clinical and pathological parameters

Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer

The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma

M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer

M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1

Integration of single-cell and bulk transcriptome analyses unravels a macrophage-based gene signature for prognostication and treatment in triple-negative breast cancer

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry

Examining the influence of tumor-infiltrating macrophages on breast cancer outcomes and identifying relevant genes for diagnostic purposes

Macrophage balance fraction determines the degree of immunosuppression and metastatic ability of breast cancer

CD68 positive and/or CD163 positive tumor-associated macrophages and PD-L1 expression in breast phyllodes tumor

Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages

Abstract 6628: Mapping the spatial and molecular determinants of macrophage heterogeneity in breast cancer

Monocyte Differentiation towards Protumor Activity Does Not Correlate with M1 or M2 Phenotypes

Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer

Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway

MED1 induces M2 polarization of tumor-associated macrophages to aggravate breast cancer

M2 macrophages predicted the prognosis of breast cancer by combing a novel immune cell signature and promoted cell migration and invasion of cancer cells in vitro

Impact of the immune molecular profile of the tumor microenvironment on the prognosis of NSCLC

The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment

The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma

Identification of Genes Associated with Prognosis and Immunotherapy Prediction in Triple-Negative Breast Cancer via M1/M2 Macrophage Ratio